Leadership

Tony has over 20 years of biotech R&D experience in building out drug pipelines, and he has played a key role in developing and successfully advancing 3 new drug modalities towards the market and in helping build several multi-billion dollar companies from start-up stage including Ablynx, Moderna and Alnylam.

Simon has over 20  years’ experience in pharmaceutical Business Development, Product Portfolio Strategy, Corporate Strategy and operational experience in international markets. Before joining Evox he was VP Corporate Strategy at Gyroscope Therapeutics and held leadership roles at Astellas in Corporate Strategy and Business Development. 

Bo has over 30 years’ experience in the biotechnology industry. He has expertise in the development of CMC for a wide range of protein, viral vector and cell therapy medicinal products. Prior to joining Evox Therapeutics, Bo was Head Process Development, Cell Gene Therapy at GSK.

Per has over 10 years of experience in advising, founding and leading biotech companies developing groundbreaking therapies. Prior to co-founding Evox in 2016, he founded and led a cell therapy company, practiced patent law as a European Patent Attorney and worked in business development and consulting.